
--- Page 1 ---
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
DECISION SUMMARY
ASSAY ONLY TEMPLATE
A. 510(k) Number:
k112337
B. Purpose for Submission:
New Device
C. Measurand:
Serum quality control materials containing the following analytes: 17-OH-progesterone,
Aldosterone, Alpha fetoprotein, Amikacin, Carbamazepine, Carcinoembrionic Antigen
(CEA), Cortisol, DHEA-S, Digoxin, Ethosuximide, Ferritin, Folate, Free T3, Free T4, FSH,
Gentamicin, Growth Hormone (GH), Immunoglobulin E, Insulin, Luteinizing Hormone
(LH), Estradiol, Acetaminophen, Phenytoin, Primidone, Progesterone, Prolactin, PSA Free,
PSA Total, Salicylic Acid, SHBG, T Uptake, Testosterone, Theophylline, Thyroid
Stimulating Hormone, Tobramycin, Total Beta hCG, Total T3, Total T4, Valproic Acid,
Vancomycin and Vitamin B12.
D. Type of Test:
Not Applicable.
E. Applicant:
Randox Laboratories LTD.
F. Proprietary and Established Names:
Randox Liquid Immunoassay Premium Controls, Level 1, level 2, Level 3 and Tri Level
G. Regulatory Information:
Product Code Classification Regulation Section Panel
21 CFR § 862.1660, Quality Clinical Chemistry
JJY Class I, reserved
control material (75)
H. Intended Use:
1. Intended use(s):
Please see indications for use below.
1

[Table 1 on page 1]
	Product Code			Classification			Regulation Section			Panel	
JJY			Class I, reserved			21 CFR § 862.1660, Quality
control material			Clinical Chemistry
(75)		

--- Page 2 ---
2. Indication(s) for use:
The Randox Liquid Immunoassay Premium Controls, Level 1, Level 2, Level 3 and Tri
Level are liquid controls developed for use in the quality control of quantitative assays
stated in the package insert.
3. Special conditions for use statement(s):
For prescription use.
4. Special instrument requirements:
Performance was evaluated on the following instrument systems: Abbott Architect,
Abbott AXSYM, Roche Cobas 6000, Roche Modular E170, Roche Elecsys, Roche Cobas
E411, Roche Integra, bioMerieux Vidas, Siemens Immulite 1000, Siemens Immulite
1000 1st generation, Siemens Immulite 2000/2500, Siemens Advia Centaur, Beckman
Access, Beckman Dxl800, Beckman Access, Vitros ECi and Vitros, Tosoh (model
A1A360), Diasorin Liaison.
I. Device Description:
The Randox Liquid Immunoassay Premium Controls are ready to use, liquid controls
derived from human based serum. The Human based serum from which this product is
derived has been tested by FDA approved methods at donor level for the Human
Immunodeficiency Virus (HIV 1, HIV 2) antibody, Hepatitis B Surface Antigen (HbsAg)
and Hepatitis C Virus (HCV) antibody and found to be non-reactive. Each control level is
purchased separately or as a kit (Tri Level) and is packaged in 12 x 5ml bottles.
J. Substantial Equivalence Information:
1. Predicate device name(s):
Bio-Rad Liquichek Immunoassay Plus Controls Level 1, 2 and 3.
2. Predicate 510(k) number(s):
k001373
3. Comparison with predicate:
Bio-Rad Liquichek
Randox Liquid Immunoassay Premium Controls,
Immunoassay Plus
Characteristics Level 1, level 2, Level 3 and Tri Level (Candidate
Controls Level 1, 2 and
Device)
3 (Predicate - k001373)
The Randox Liquid Immunoassay Premium Controls, Level
Indication for use / 1, Level 2, Level 3 and Tri Level are liquid controls
Same
Intended for Use developed for use in the quality control of quantitative assays
stated in the package insert.
Test System Abbott Architect, Abbott AXSYM, Roche Cobas 6000, Roche
Same
(Instrumentation / Modular E170, Roche Elecsys, Roche Cobas E411, Roche
2

[Table 1 on page 2]
Characteristics	Randox Liquid Immunoassay Premium Controls,
Level 1, level 2, Level 3 and Tri Level (Candidate
Device)	Bio-Rad Liquichek
Immunoassay Plus
Controls Level 1, 2 and
3 (Predicate - k001373)
Indication for use /
Intended for Use	The Randox Liquid Immunoassay Premium Controls, Level
1, Level 2, Level 3 and Tri Level are liquid controls
developed for use in the quality control of quantitative assays
stated in the package insert.	Same
Test System
(Instrumentation /	Abbott Architect, Abbott AXSYM, Roche Cobas 6000, Roche
Modular E170, Roche Elecsys, Roche Cobas E411, Roche	Same

--- Page 3 ---
technology) Integra, bioMerieux Vidas, Siemens Immulite 1000, Siemens
Immulite 1000 1st generation, Siemens Immulite 2000/2500,
Siemens Advia Centaur, Beckman Access, Beckman Dxl800,
Beckman Access, Vitros ECi and Vitros, Tosoh (model
A1A360), Diasorin Liaison.
17-OH-progesterone, Aldosterone, Alpha fetoprotein,
Amikacin, Carbamazepine, Carcinoembryonic Antigen
(CEA), Cortisol, DHEA-S, Digoxin, Ethosuximide, Ferritin,
Folate, Free T3, Free T4, FSH, Gentamicin, Growth Hormone
(GH), Immunoglobulin E, Insulin, Luteinizing Hormone
Analyte Same
(LH), Estradiol, Acetaminophen, Phenytoin, Primidone,
Progesterone, Prolactin, PSA Free, PSA Total, Salicylic Acid,
SHBG, T Uptake, Testosterone, Theophylline, Thyroid
Stimulating Hormone, Tobramycin, Total Beta hCG, Total
T3, Total T4, Valproic Acid, Vancomycin and Vitamin B12.
Opened: 14 days when
stored at 2-8°C, with the
Opened: 7 days @ 2-8ºC exception of: Folate 4 days
Stability claim / and Estradiol 5 days.
Storage
Temperature Thaw Unopened: 30 days with
Unopened: 30 days @ 2-8ºC exception of Folate 4 days,
Estradiol 8 days, Free PSA,
PSA and Prolactin 14 days.
Shelf life 12 months @ -20 to - 70 28 months @ -20
K. Standard/Guidance Document Referenced (if applicable):
None referenced
L. Test Principle:
Not applicable.
M. Performance Characteristics (if/when applicable):
1. Analytical performance:
a. Precision/Reproducibility:
Not applicable.
b. Linearity/assay reportable range:
Not applicable.
c. Traceability, Stability, Expected values (controls, calibrators, or methods):
Traceability and Value Assignment
Control solutions are derived from gravimetrically prepared stock solutions and
analyzed in-house. Each lot of Liquid Immunoassay Premium is submitted to a
number of reference laboratories using multiple instruments and values are assigned
3

[Table 1 on page 3]
technology)	Integra, bioMerieux Vidas, Siemens Immulite 1000, Siemens
Immulite 1000 1st generation, Siemens Immulite 2000/2500,
Siemens Advia Centaur, Beckman Access, Beckman Dxl800,
Beckman Access, Vitros ECi and Vitros, Tosoh (model
A1A360), Diasorin Liaison.	
Analyte	17-OH-progesterone, Aldosterone, Alpha fetoprotein,
Amikacin, Carbamazepine, Carcinoembryonic Antigen
(CEA), Cortisol, DHEA-S, Digoxin, Ethosuximide, Ferritin,
Folate, Free T3, Free T4, FSH, Gentamicin, Growth Hormone
(GH), Immunoglobulin E, Insulin, Luteinizing Hormone
(LH), Estradiol, Acetaminophen, Phenytoin, Primidone,
Progesterone, Prolactin, PSA Free, PSA Total, Salicylic Acid,
SHBG, T Uptake, Testosterone, Theophylline, Thyroid
Stimulating Hormone, Tobramycin, Total Beta hCG, Total
T3, Total T4, Valproic Acid, Vancomycin and Vitamin B12.	Same
Stability claim /
Storage
Temperature Thaw	Opened: 7 days @ 2-8ºC
Unopened: 30 days @ 2-8ºC	Opened: 14 days when
stored at 2-8°C, with the
exception of: Folate 4 days
and Estradiol 5 days.
Unopened: 30 days with
exception of Folate 4 days,
Estradiol 8 days, Free PSA,
PSA and Prolactin 14 days.
Shelf life	12 months @ -20 to - 70	28 months @ -20

--- Page 4 ---
from a consensus of the results obtained by these laboratories. With each lot a control
range is provided for each analyte and instrument. The control range is equivalent to
the mean ±2 SD. Assigned control ranges are listed in the labeling by instrument and
analyte.
Stability
Real time stability study protocols and acceptance criteria were described and found to be
acceptable.
The stability claim for the controls is 12 months at -20 to -70 ºC for unopened vials.
Thawed unopened vials stability claim is 30 days when stored at 2-8ºC. Thaw
stability claim for opened vials is 7 days when stored at 2-8ºC.
d. Detection limit:
Not applicable.
e. Analytical specificity:
Not applicable.
f. Assay cut-off:
Not applicable.
2. Comparison studies:
a. Method comparison with predicate device:
Not applicable.
b. Matrix comparison:
Not applicable.
3. Clinical studies:
a. Clinical Sensitivity:
Not applicable.
b. Clinical specificity:
Not applicable.
4

--- Page 5 ---
c. Other clinical supportive data (when a. and b. are not applicable):
Not applicable.
4. Clinical cut-off:
Not applicable.
5. Expected values/Reference range:
Expected values and control ranges are provided in the package insert.
N. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
O. Conclusion:
The submitted information in this premarket notification is complete and supports a
substantial equivalence decision.
5